Increasing RN staffing hours reduces injury-related ED visits by assisted living residents with dementia:...
By
Kimberly Bonvissuto
Jul 19, 2024
A new study found that increasing staffing hours of registered nurses in assisted living communities led to a 53% decrease in injury-related emergency department visits by residents living with Alzheimer’s...
FDA clears nasal spray for moderate Alzheimer’s disease in first patient
By
Donna Shryer
Jul 16, 2024
Two recent developments in Alzheimer’s disease research offer new hope for patients and their families. Among these, in June, Tiziana Life Sciences received Food and Drug Administration clearance...
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
State dementia oversight efforts must include representatives from entire long-term care continuum, experts...
By
Kimberly Bonvissuto
Jul 10, 2024
The potential creation of a permanent state division and advisory committee dedicated to Alzheimer’s disease and related disorders has won praise from Pennsylvania’s senior living industry advocates,...
New laws increase public awareness, funding for dementia initiatives
By
Kimberly Bonvissuto
Jul 09, 2024
Increasing public awareness of Alzheimer’s and other forms of dementia, along with increasing services for people with diagnoses and their caregivers, are front and center in recent state initiatives...
More news for Wednesday, July 3, 2024
By
Kimberly Bonvissuto
Jul 03, 2024
Sonida Senior Living acquires 9 communities, to manage 2 more … FDA approves donanemab treatment for early Alzheimer’s disease … House subcommittee advances proposal to cut HUD funding by 7% …...
FDA approves new drug to treat Alzheimer’s
Jul 02, 2024
In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
Cognitive impairment delayed with genetic variant
Jun 20, 2024
The onset of cognitive impairment was delayed among those heterozygous for the apolipoprotein E3 Christchurch variant.
Business briefs, June 18
By
Kathleen Steele Gaivin
Jun 18, 2024
Brookdale Senior Living to add gerontologist … CaringKind raises $1.4M at annual gala in support of Alzheimer’s, dementia care … Fitch Ratings affirms Wesley Enhanced Living’s IDR at BB; outlook...